Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,963 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Chemotherapy for advanced pancreatic cancer.
Chua YJ, Cunningham D. Chua YJ, et al. Best Pract Res Clin Gastroenterol. 2006 Apr;20(2):327-48. doi: 10.1016/j.bpg.2005.10.003. Best Pract Res Clin Gastroenterol. 2006. PMID: 16549331 Review.
Failure of conventional chemotherapy in aggressive lymphomas.
Cunningham D, Hepplestone A, Gilchrist NL, Dagg JH, Evans IL, Soukop M. Cunningham D, et al. Postgrad Med J. 1987 Jan;63(735):11-5. doi: 10.1136/pgmj.63.735.11. Postgrad Med J. 1987. PMID: 2444960 Free PMC article.
Cytotoxic drugs for gastric and colorectal cancer.
Cunningham D. Cunningham D. BMJ. 1989 Dec 16;299(6714):1479-80. doi: 10.1136/bmj.299.6714.1479. BMJ. 1989. PMID: 2514857 Free PMC article. Review. No abstract available.
Dose-related endocrine effects and pharmacokinetics of oral and intramuscular 4-hydroxyandrostenedione in postmenopausal breast cancer patients.
Dowsett M, Cunningham DC, Stein RC, Evans S, Dehennin L, Hedley A, Coombes RC. Dowsett M, et al. Cancer Res. 1989 Mar 1;49(5):1306-12. Cancer Res. 1989. PMID: 2917360 Clinical Trial.
Chemotherapy improves pulmonary function in a patient with gastric cancer.
Cunningham D, Henderson A, Soukop M. Cunningham D, et al. Br J Clin Pract. 1986 Jun;40(6):261-2. Br J Clin Pract. 1986. PMID: 3755609 No abstract available.
Chemotherapy in advanced gastric cancer.
Cunningham D, Gilchrist NL, Forrest GJ, Soukop M, McArdle CS, Carter DC. Cunningham D, et al. Cancer Treat Rep. 1985 Jul-Aug;69(7-8):927-8. Cancer Treat Rep. 1985. PMID: 4016803 No abstract available.
Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours.
Ellis PA, Norman A, Hill A, O'Brien ME, Nicolson M, Hickish T, Cunningham D. Ellis PA, et al. Eur J Cancer. 1995 Sep;31A(10):1594-8. doi: 10.1016/0959-8049(95)00323-b. Eur J Cancer. 1995. PMID: 7488407 Clinical Trial.
Impact of protracted venous infusion fluorouracil with or without interferon alfa-2b on tumor response, survival, and quality of life in advanced colorectal cancer.
Hill M, Norman A, Cunningham D, Findlay M, Watson M, Nicolson V, Webb A, Middleton G, Ahmed F, Hickish T, et al. Hill M, et al. J Clin Oncol. 1995 Sep;13(9):2317-23. doi: 10.1200/JCO.1995.13.9.2317. J Clin Oncol. 1995. PMID: 7666089 Clinical Trial.
PATIENTS AND METHODS: Patients who attended our unit with histologically confirmed advanced colorectal cancer were randomized to receive either PVI 5-FU 300 mg/m2/d via Hickman line, and IFN 5 MU subcutaneously three times weekly, or PVI 5-FU alone. ...
PATIENTS AND METHODS: Patients who attended our unit with histologically confirmed advanced colorectal cancer were randomized to receive eit …
Royal Marsden phase III trial of fluorouracil with or without interferon alfa-2b in advanced colorectal cancer.
Hill M, Norman A, Cunningham D, Findlay M, Nicolson V, Hill A, Iveson A, Evans C, Joffe J, Nicolson M, et al. Hill M, et al. J Clin Oncol. 1995 Jun;13(6):1297-302. doi: 10.1200/JCO.1995.13.6.1297. J Clin Oncol. 1995. PMID: 7751874 Clinical Trial.
PATIENTS AND METHODS: Patients with histologically confirmed advanced colorectal cancer were randomized to receive 5-FU 750 mg/m2/d by continuous infusion for 5 consecutive days followed by weekly bolus 5-FU 750 mg/m2 either with or without IFN 10 MU subcutaneously three t …
PATIENTS AND METHODS: Patients with histologically confirmed advanced colorectal cancer were randomized to receive 5-FU 750 mg/m2/d b …
1,963 results
Jump to page
Feedback